Low-Income Men More Likely to be Diagnosed with Advanced Prostate Cancers
Wednesday, December 17 2008 00:00
Low-income men are more likely to present with advanced prostate cancers, most likely because they don’t receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found.The study focused on a group of disadvantaged men enrolled in the state’s IMPACT (Improving Access, Counseling and Treatment for Californians with Prostate Cancer) program, which provides high-quality care to poor, underinsured and uninsured men. Researchers found that of the 570 men studied, 19 percent had metastatic cancer at diagnosis, compared to 4 percent of men from the general population who were followed in other studies.
Read more: Low-Income Men More Likely to be Diagnosed with Advanced Prostate Cancers
Pre-Existing Diabetes Raises Cancer Patients' Risks
Prostate Cancer Plus - Diabetes
By Monday, December 15 2008 18:56
People with diabetes at the time of a cancer diagnosis have an increased risk of death compared to patients without diabetes, according to a study led by Frederick Brancati, M.D., Johns Hopkins University and published in the December 17 issue of The Journal of the American Medical Association today.
Read more: Pre-Existing Diabetes Raises Cancer Patients' Risks
Androgen Blockade for Prostate Cancer May Not Cause Excess Cardiac Deaths
Thursday, December 11 2008 03:27
Other adverse effects remain, requiring careful balancing of benefits with risks
Treating prostate cancer patients with drugs that block male hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers. But the treatment does increase risks of diabetes and heart disease. How can this outcome hold true?
Read more: Androgen Blockade for Prostate Cancer May Not Cause Excess Cardiac Deaths
Selenium Blood Levels and Prostate Cancer Risk, European Results
Last Updated (Thursday, December 18 2008 12:13) Monday, December 08 2008 07:10
Selenium is widely sold to men who takein supplement form witht he aim of preventing prostate cancer. Now evidence from a large study suggests that selenium does not offer the protection hoped for.
Read more: Selenium Blood Levels and Prostate Cancer Risk, European Results
Suppressing GRP78 Halts Prostate Cancer Development
Tuesday, November 25 2008 00:00
Inactivating a specific biomarker for aggressive prostate cancer, called GRP78, blocks the development of prostate cancer in animal models according to researchers at the University of Southern California (USC). This breakthrough discovery may lead to a novel cancer therapy for humans.
Read more: Suppressing GRP78 Halts Prostate Cancer Development
More Articles...
JPAGE_CURRENT_OF_TOTAL
